Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of STELARA patients who developed NECK PAIN.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 81 individuals taking STELARA reported NECK PAIN to the FDA. A total of 5762 STELARA drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between STELARA and NECK PAIN. In doing so, we compare STELARA with other drugs that cause NECK PAIN, to help you evaluate whether or not STELARA causes NECK PAIN. Likewise, this page shows the most highly-reported side effects of STELARA, so you can see if NECK PAIN ranks among STELARA's most well-known side effects.
Summary Statistics
Reports of STELARA causing NECK PAIN: 81
Reports of any side effect of STELARA : 5762
Percentage of STELARA patients where NECK PAIN is a reported side effect: 1.4058%

FDA reports of any drug causing NECK PAIN : 16024
Average percentage for all medicated patients where NECK PAIN is reported as a complication: 0.1004%

Physician opinion on STELARA as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing STELARA:
PSORIASIS ( 2736 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 432 patients )
PSORIATIC ARTHROPATHY ( 94 patients )
ILL-DEFINED DISORDER ( 41 patients )
DRUG USE FOR UNKNOWN INDICATION ( 34 patients )
PUSTULAR PSORIASIS ( 29 patients )
CROHN'S DISEASE ( 24 patients )
DERMATITIS ATOPIC ( 10 patients )
ARTHRITIS ( 9 patients )
PYODERMA GANGRENOSUM ( 9 patients )
HIDRADENITIS ( 6 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 5 patients )
GUTTATE PSORIASIS ( 4 patients )
NAIL PSORIASIS ( 3 patients )
ERYTHRODERMIC PSORIASIS ( 3 patients )
EXPOSURE VIA SEMEN ( 3 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 2 patients )
EXPOSURE VIA FATHER ( 2 patients )
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS ( 2 patients )
AUTOIMMUNE DISORDER ( 2 patients )
DRUG EXPOSURE DURING PREGNANCY ( 2 patients )
PARAPSORIASIS ( 1 patients )
DERMATITIS EXFOLIATIVE ( 1 patients )
FISTULA ( 1 patients )
RHEUMATOID ARTHRITIS ( 1 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 1 patients )
PITYRIASIS RUBRA PILARIS ( 1 patients )
PULMONARY EMBOLISM ( 1 patients )
PYODERMA ( 1 patients )
RESPIRATORY DISORDER ( 1 patients )
SARCOIDOSIS ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with NECK PAIN:

FOSAMAX (2895 patients)
VIOXX (2540 patients)
ASPIRIN (1547 patients)
ZOMETA (1305 patients)
FORTEO (1050 patients)
ENBREL (1044 patients)
HUMIRA (973 patients)
SEROQUEL (967 patients)
NEXIUM (930 patients)
LIPITOR (928 patients)
AREDIA (894 patients)
SYNTHROID (813 patients)
PREDNISONE (794 patients)
XANAX (783 patients)
NEURONTIN (776 patients)
AMBIEN (759 patients)
PRILOSEC (706 patients)
CELEBREX (674 patients)
ZOLOFT (625 patients)
VICODIN (625 patients)
COUMADIN (597 patients)
LASIX (597 patients)
PREVACID (587 patients)
LYRICA (583 patients)
TYSABRI (578 patients)
LISINOPRIL (570 patients)
ZOCOR (556 patients)
PERCOCET (552 patients)
OXYCONTIN (551 patients)
IBUPROFEN (537 patients)
AVONEX (527 patients)
OMEPRAZOLE (514 patients)
LEVAQUIN (514 patients)
PROTONIX (512 patients)
METHOTREXATE (511 patients)
ATENOLOL (507 patients)
EFFEXOR (502 patients)
FLEXERIL (495 patients)
CYMBALTA (492 patients)
CRESTOR (489 patients)
VITAMIN D (485 patients)
LEXAPRO (484 patients)
NORVASC (473 patients)
FOLIC ACID (470 patients)
ALBUTEROL (457 patients)
PREMARIN (448 patients)
SIMVASTATIN (447 patients)
HYDROCHLOROTHIAZIDE (435 patients)
ATIVAN (432 patients)
PAXIL (431 patients)
ACETAMINOPHEN (427 patients)
FUROSEMIDE (417 patients)
CALCIUM (412 patients)
PLAVIX (410 patients)
ACCUTANE (406 patients)
PROZAC (404 patients)
GABAPENTIN (400 patients)
DURAGESIC-100 (400 patients)
LORAZEPAM (382 patients)
TOPROL-XL (379 patients)
SANDOSTATIN LAR (377 patients)
CLONAZEPAM (375 patients)
REMICADE (371 patients)
OXYCODONE HCL (369 patients)
AMOXICILLIN (354 patients)
LEVOTHYROXINE SODIUM (353 patients)
MULTI-VITAMINS (340 patients)
WELLBUTRIN (340 patients)
HEPARIN SODIUM INJECTION (339 patients)
BONIVA (337 patients)
ACTONEL (332 patients)
POTASSIUM CHLORIDE (320 patients)
DIGOXIN (315 patients)
ZOFRAN (309 patients)
MORPHINE (307 patients)
DECADRON (306 patients)
ALLEGRA (304 patients)
ELAVIL (303 patients)
CELEXA (301 patients)
DIOVAN (298 patients)
KLONOPIN (297 patients)
SINGULAIR (297 patients)
DEXAMETHASONE (296 patients)
ALPRAZOLAM (295 patients)
VALIUM (292 patients)
LORTAB (290 patients)
MODOPAR (281 patients)
CIPRO (281 patients)
DIAZEPAM (272 patients)
CLINDAMYCIN (269 patients)
ZANTAC (268 patients)
CHEMOTHERAPEUTICS NOS (264 patients)
CHANTIX (260 patients)
METFORMIN HCL (260 patients)
FOSAMAX PLUS D (260 patients)
ULTRAM (258 patients)
NITROGLYCERIN (258 patients)
ALENDRONATE SODIUM (257 patients)
ARIMIDEX (257 patients)
NAPROXEN (251 patients)
SKELAXIN (251 patients)
REGLAN (248 patients)
VITAMIN E (248 patients)
TRAZODONE HCL (242 patients)
PREDNISONE TAB (242 patients)
HYDROCODONE BITARTRATE (237 patients)
DILAUDID (237 patients)
ADVAIR DISKUS 100/50 (236 patients)
ALLOPURINOL (235 patients)
BOTOX (235 patients)
WARFARIN SODIUM (234 patients)
INSULIN (234 patients)
AMITRIPTYLINE HCL (234 patients)
RISPERDAL CONSTA (233 patients)
FENTANYL (233 patients)
BACLOFEN (233 patients)
ZITHROMAX (232 patients)
METOPROLOL TARTRATE (230 patients)
ZYRTEC (230 patients)
RADIATION THERAPY (230 patients)
SOMA (228 patients)
RECLAST (223 patients)
BENADRYL (222 patients)
TRAMADOL HCL (220 patients)
TYLENOL (CAPLET) (217 patients)
MORPHINE SULFATE (215 patients)
TAMOXIFEN CITRATE (215 patients)
TYLENOL (214 patients)
MULTI-VITAMIN (214 patients)
CLARITIN (207 patients)
VITAMIN B-12 (206 patients)
CIPROFLOXACIN (205 patients)
CALCIUM CARBONATE (204 patients)
AUGMENTIN '125' (203 patients)
ASCORBIC ACID (201 patients)
AVELOX (200 patients)
HYDROCODONE (200 patients)
ACIPHEX (199 patients)
VITAMINS (UNSPECIFIED) (197 patients)
RISPERDAL (196 patients)
FLONASE (195 patients)
TAXOTERE (194 patients)
PEPCID (192 patients)
FASLODEX (192 patients)
FISH OIL (192 patients)
LANTUS (191 patients)
MOTRIN (189 patients)
FLOMAX (187 patients)
GAMMAGARD LIQUID (185 patients)
TOPAMAX (185 patients)
MS CONTIN (185 patients)
COMPAZINE (185 patients)
BEXTRA (184 patients)
ZYPREXA (183 patients)
[THERAPY UNSPECIFIED] (182 patients)
NIASPAN (181 patients)
COREG (180 patients)
NYSTATIN (180 patients)
FLUCONAZOLE (180 patients)
THALIDOMIDE (175 patients)
LOVENOX (175 patients)
FLAGYL (174 patients)
FEMARA (173 patients)
CEPHALEXIN (172 patients)
LOPRESSOR (171 patients)
ALTACE (171 patients)
CARBOPLATIN (169 patients)
METOPROLOL (168 patients)
CHLORHEXIDINE GLUCONATE (168 patients)
ARANESP (167 patients)
DEPAKOTE (167 patients)
KEFLEX (167 patients)
GLUCOPHAGE (166 patients)
MIRALAX (165 patients)
METOCLOPRAMIDE (165 patients)
XELODA (161 patients)
PROCRIT /00909301/ (158 patients)
ADRIAMYCIN PFS (158 patients)
NASONEX (157 patients)
VALTREX (157 patients)
LIDOCAINE (156 patients)
COZAAR (156 patients)
ZETIA (155 patients)
CLONIDINE (153 patients)
COLACE (152 patients)
RANITIDINE (152 patients)
LAMICTAL (151 patients)
FLUOXETINE (151 patients)
LIDODERM (149 patients)
REBIF (149 patients)
POTASSIUM (148 patients)
ACYCLOVIR (148 patients)
PREDNISOLONE (146 patients)
PERIDEX (146 patients)
REVLIMID (145 patients)
NORCO (145 patients)
TEMAZEPAM (141 patients)
EFFEXOR XR (141 patients)
OXYCODONE (141 patients)
NUVARING (141 patients)
BYETTA (140 patients)
MAGNESIUM (140 patients)
EVISTA (139 patients)
KLOR-CON (139 patients)
ZESTRIL (139 patients)
IMITREX (139 patients)
VYTORIN (139 patients)
SPIRIVA (138 patients)
DOXYCYCLINE (137 patients)
MOBIC (137 patients)
Most common side effects for patients taking STELARA:
PSORIASIS (698 patients)
DRUG INEFFECTIVE (329 patients)
HEADACHE (283 patients)
MYOCARDIAL INFARCTION (221 patients)
PNEUMONIA (210 patients)
ARTHRALGIA (185 patients)
FATIGUE (181 patients)
DIZZINESS (178 patients)
DYSPNOEA (159 patients)
DEPRESSION (156 patients)
CELLULITIS (155 patients)
PYREXIA (131 patients)
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION (129 patients)
CEREBROVASCULAR ACCIDENT (125 patients)
OFF LABEL USE (118 patients)
PSORIATIC ARTHROPATHY (117 patients)
PRURITUS (114 patients)
BLOOD GLUCOSE INCREASED (110 patients)
NAUSEA (96 patients)
CONDITION AGGRAVATED (95 patients)
CROHN'S DISEASE (94 patients)
NASOPHARYNGITIS (93 patients)
LOWER RESPIRATORY TRACT INFECTION (93 patients)
VISUAL IMPAIRMENT (92 patients)
ARTHRITIS (91 patients)
COUGH (90 patients)
HOSPITALISATION (90 patients)
STAPHYLOCOCCAL INFECTION (90 patients)
MALAISE (86 patients)
OEDEMA PERIPHERAL (84 patients)
BLOOD CHOLESTEROL INCREASED (84 patients)
HYPERTENSION (83 patients)
NECK PAIN (81 patients)
ASTHENIA (81 patients)
DIABETES MELLITUS (81 patients)
PAIN IN EXTREMITY (81 patients)
CONFUSIONAL STATE (78 patients)
ANXIETY (78 patients)
WEIGHT DECREASED (76 patients)
MYALGIA (75 patients)
DEATH (75 patients)
RENAL IMPAIRMENT (75 patients)
OROPHARYNGEAL PAIN (74 patients)
URINARY TRACT INFECTION (74 patients)
DIARRHOEA (72 patients)
LIVER DISORDER (71 patients)
VISION BLURRED (71 patients)
UPPER RESPIRATORY TRACT INFECTION (70 patients)
THERAPEUTIC RESPONSE DECREASED (70 patients)
SEPSIS (69 patients)
RASH (66 patients)
DRUG DOSE OMISSION (66 patients)
PUSTULAR PSORIASIS (65 patients)
SINUSITIS (64 patients)
LIVER FUNCTION TEST ABNORMAL (63 patients)
HERPES ZOSTER (62 patients)
SYNCOPE (62 patients)
WEIGHT INCREASED (61 patients)
BACK PAIN (60 patients)
PROSTATE CANCER (59 patients)
FALL (59 patients)
CHEST PAIN (57 patients)
PAIN (55 patients)
BRONCHITIS (55 patients)
INTRAOCULAR PRESSURE INCREASED (54 patients)
SQUAMOUS CELL CARCINOMA (54 patients)
HEPATIC FUNCTION ABNORMAL (53 patients)
HEPATIC ENZYME INCREASED (53 patients)
CONVULSION (52 patients)
PULMONARY EMBOLISM (49 patients)
HYPERSENSITIVITY (48 patients)
HYPOACUSIS (48 patients)
BLOOD PRESSURE ABNORMAL (47 patients)
B-CELL LYMPHOMA (46 patients)
INFECTION (46 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (46 patients)
HYPERHIDROSIS (45 patients)
OSTEOMYELITIS (44 patients)
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES (44 patients)
KNEE ARTHROPLASTY (44 patients)
BLOOD PRESSURE INCREASED (43 patients)
INFLUENZA (42 patients)
HEPATIC STEATOSIS (41 patients)
RENAL FAILURE (41 patients)
VOMITING (41 patients)
VERTIGO (40 patients)
MUSCULOSKELETAL STIFFNESS (40 patients)
ANAEMIA (39 patients)
ASTHMA (39 patients)
GAIT DISTURBANCE (39 patients)
DEMENTIA (39 patients)
CARDIAC DISORDER (39 patients)
URTICARIA (38 patients)
FEELING ABNORMAL (36 patients)
DECREASED INTEREST (36 patients)
TYPE 2 DIABETES MELLITUS (35 patients)
BREAST CANCER (35 patients)
MULTIPLE SCLEROSIS (34 patients)
DYSARTHRIA (34 patients)
ATRIAL FIBRILLATION (34 patients)
GUILLAIN-BARRE SYNDROME (34 patients)
GASTROENTERITIS (33 patients)
DISTURBANCE IN ATTENTION (33 patients)
DIVERTICULITIS (33 patients)
CHILLS (33 patients)
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED (32 patients)
AMNESIA (32 patients)
HEPATITIS C (32 patients)
VIITH NERVE PARALYSIS (31 patients)
ASCITES (31 patients)
CARDIO-RESPIRATORY ARREST (31 patients)
PANCYTOPENIA (30 patients)
ABDOMINAL PAIN (30 patients)
MATERNAL EXPOSURE DURING PREGNANCY (30 patients)
ALANINE AMINOTRANSFERASE INCREASED (30 patients)
LOCALISED INFECTION (30 patients)
LYMPHADENITIS (30 patients)
BALANCE DISORDER (30 patients)
NEUROPATHY PERIPHERAL (30 patients)
RENAL FAILURE ACUTE (30 patients)
ABDOMINAL DISCOMFORT (29 patients)
MUSCULAR WEAKNESS (29 patients)
PLATELET COUNT DECREASED (29 patients)
ERYTHEMA (29 patients)
DYSPHAGIA (29 patients)
LYMPHADENOPATHY (29 patients)
SWELLING (29 patients)
INFLUENZA LIKE ILLNESS (29 patients)
PLEURAL EFFUSION (28 patients)
CHOLECYSTITIS (28 patients)
LETHARGY (28 patients)
SLEEP APNOEA SYNDROME (27 patients)
HEPATIC CIRRHOSIS (27 patients)
CATARACT (27 patients)
STREPTOCOCCAL INFECTION (27 patients)
HYPERTENSIVE HEART DISEASE (26 patients)
TRANSIENT ISCHAEMIC ATTACK (26 patients)
COELIAC DISEASE (26 patients)
DYSURIA (26 patients)
GUTTATE PSORIASIS (26 patients)
THROMBOCYTOPENIA (25 patients)
LOSS OF CONSCIOUSNESS (25 patients)
PULMONARY MASS (25 patients)
DRUG EFFECT DECREASED (25 patients)
HYPOAESTHESIA (25 patients)
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE (25 patients)
ARTERIOSCLEROSIS (25 patients)
INCORRECT DRUG ADMINISTRATION DURATION (25 patients)
JOINT DISLOCATION (25 patients)
TUBERCULOSIS (25 patients)
PANCREATITIS (25 patients)
HEPATIC NEOPLASM MALIGNANT (25 patients)
UPPER LIMB FRACTURE (25 patients)
LUNG DISORDER (25 patients)
AGGRESSION (24 patients)
FEELING HOT (24 patients)
RASH PUSTULAR (24 patients)
TOOTH INFECTION (24 patients)
ANGIOEDEMA (24 patients)
HAEMATOCHEZIA (24 patients)
MALIGNANT MELANOMA (23 patients)
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (23 patients)
DISORIENTATION (23 patients)
CHOLELITHIASIS (23 patients)
GASTROINTESTINAL HAEMORRHAGE (23 patients)
CARDIAC FAILURE (23 patients)
CARDIAC FAILURE CONGESTIVE (23 patients)
ACTINIC KERATOSIS (22 patients)
PHARYNGITIS STREPTOCOCCAL (22 patients)
MOTOR DYSFUNCTION (22 patients)
TRANSAMINASES INCREASED (22 patients)
HAEMATURIA (22 patients)
BLISTER (22 patients)
SKIN CANCER (22 patients)
FACIAL PALSY (22 patients)
WHITE BLOOD CELL COUNT INCREASED (22 patients)
DEEP VEIN THROMBOSIS (22 patients)
LYMPHOMA (22 patients)
SPEECH DISORDER (21 patients)
LATENT TUBERCULOSIS (21 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (21 patients)
MEMORY IMPAIRMENT (21 patients)
MIGRAINE (21 patients)
MOLE EXCISION (21 patients)
C-REACTIVE PROTEIN INCREASED (21 patients)
ABORTION SPONTANEOUS (20 patients)
POST-TRAUMATIC STRESS DISORDER (20 patients)
DERMATITIS EXFOLIATIVE (20 patients)
LARYNGEAL CANCER (20 patients)
SEPTIC SHOCK (20 patients)
EAR INFECTION (20 patients)
ARTHROSCOPY (20 patients)
ATAXIA (20 patients)
SQUAMOUS CELL CARCINOMA OF SKIN (20 patients)
LEG AMPUTATION (20 patients)
UNDERDOSE (19 patients)
RESPIRATORY TRACT INFECTION (19 patients)
URINARY RETENTION (19 patients)
MULTIPLE MYELOMA (19 patients)
CHEST DISCOMFORT (19 patients)
LACERATION (19 patients)
THROMBOSIS (19 patients)
PARAESTHESIA (19 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (19 patients)
TOE AMPUTATION (19 patients)
ADVERSE EVENT (18 patients)
DEMYELINATION (18 patients)
DIPLOPIA (18 patients)
SKIN PLAQUE (18 patients)
NASAL CONGESTION (18 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for STELARA


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about NECK PAIN and STELARA, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking STELARA, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in STELARA. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for STELARA experts. If you are a healthcare provider experienced in prescribing STELARA, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use